160 related articles for article (PubMed ID: 38717445)
1. Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic.
Martin FP; Cominetti O; Berger B; Combremont S; Marquis J; Xie G; Jia W; Pinto-Sanchez MI; Bercik P; Bergonzelli G
Gut Microbes; 2024; 16(1):2347715. PubMed ID: 38717445
[TBL] [Abstract][Full Text] [Related]
2. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
4. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
5. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients.
Liu T; Gu X; Li LX; Li M; Li B; Cui X; Zuo XL
BMC Microbiol; 2020 Jun; 20(1):168. PubMed ID: 32552668
[TBL] [Abstract][Full Text] [Related]
6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
7. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of
Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
10. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity.
Han L; Zhao L; Zhou Y; Yang C; Xiong T; Lu L; Deng Y; Luo W; Chen Y; Qiu Q; Shang X; Huang L; Mo Z; Huang S; Huang S; Liu Z; Yang W; Zhai L; Ning Z; Lin C; Huang T; Cheng C; Zhong LLD; Li S; Bian Z; Fang X
ISME J; 2022 Apr; 16(4):983-996. PubMed ID: 34750528
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
[TBL] [Abstract][Full Text] [Related]
12. The Fragility of Probiotic Bifidobacterium longum NCC3001 Use for Depression in Patients With Irritable Bowel Syndrome.
Meyer C; Vassar M
Gastroenterology; 2018 Feb; 154(3):764. PubMed ID: 29352957
[No Abstract] [Full Text] [Related]
13. Gas chromatography/mass spectrometry based metabolomic study in a murine model of irritable bowel syndrome.
Yu LM; Zhao KJ; Wang SS; Wang X; Lu B
World J Gastroenterol; 2018 Feb; 24(8):894-904. PubMed ID: 29491683
[TBL] [Abstract][Full Text] [Related]
14. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
15. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
[TBL] [Abstract][Full Text] [Related]
16. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
[No Abstract] [Full Text] [Related]
17. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
[TBL] [Abstract][Full Text] [Related]
18. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome.
Mujagic Z; Kasapi M; Jonkers DM; Garcia-Perez I; Vork L; Weerts ZZRM; Serrano-Contreras JI; Zhernakova A; Kurilshikov A; Scotcher J; Holmes E; Wijmenga C; Keszthelyi D; Nicholson JK; Posma JM; Masclee AA
Gut Microbes; 2022; 14(1):2063016. PubMed ID: 35446234
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
[TBL] [Abstract][Full Text] [Related]
20. A Microbial Signature of Psychological Distress in Irritable Bowel Syndrome.
Peter J; Fournier C; Durdevic M; Knoblich L; Keip B; Dejaco C; Trauner M; Moser G
Psychosom Med; 2018 Oct; 80(8):698-709. PubMed ID: 30095672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
